Signase Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Signase General Information

Description

Developer of small molecule inhibitors of a critical cell pathway for the treatment of a variety of solid tumors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11711 Memorial Drive
  • Suite 522
  • Houston, TX 77024
  • United States
+1 (713)
Primary Industry
Drug Delivery
Acquirer
Vertical(s)
Corporate Office
  • 11711 Memorial Drive
  • Suite 522
  • Houston, TX 77024
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Signase Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jan-2005 Completed Generating Revenue
2. Early Stage VC (Series A) 30-Apr-2002 Completed Product Development
1. Seed Round 01-May-2000 Completed Product Development
To view Signase’s complete valuation and funding history, request access »

Signase Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioCapital Investments Limited Partner Minority
Certara Corporation Minority
Pappas Capital Venture Capital Minority
To view Signase’s complete investors history, request access »

Signase FAQs

  • When was Signase founded?

    Signase was founded in 2000.

  • Where is Signase headquartered?

    Signase is headquartered in Houston, TX.

  • What industry is Signase in?

    Signase’s primary industry is Drug Delivery.

  • Is Signase a private or public company?

    Signase is a Private company.

  • What is Signase’s current revenue?

    The current revenue for Signase is .

  • How much funding has Signase raised over time?

    Signase has raised $3.5M.

  • Who are Signase’s investors?

    BioCapital Investments, Certara, and Pappas Capital have invested in Signase.

  • When was Signase acquired?

    Signase was acquired on 01-Jan-2005.

  • Who acquired Signase?

    Signase was acquired by Systems Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process